SciGen, Israel Report issue

For profit
Founded: Rehovot Israel (2006)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2011
NCT01437475
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

hepatitis b vaccine (recombinant) (Recombivax) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1